Literature DB >> 11549574

Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology.

M Kiuru1, V Launonen, M Hietala, K Aittomäki, O Vierimaa, R Salovaara, J Arola, E Pukkala, P Sistonen, R Herva, L A Aaltonen.   

Abstract

Little has been known about the molecular background of familial multiple cutaneous leiomyomatosis (MCL). We report here a clinical, histopathological, and molecular study of a multiple cutaneous leiomyomatosis kindred with seven affected members. This detailed study revealed strong features of a recently described cancer predisposition syndrome, hereditary leiomyomatosis and renal cell cancer (HLRCC). The family was compatible with linkage to the HLRCC locus in 1q. Also, all seven cutaneous leiomyomas derived from the proband and analyzed for loss of heterozygosity displayed loss of the wild-type allele, confirming the association with a susceptibility gene in chromosome 1q. One individual had had renal cell cancer at the age of 35 years. This tumor displayed a rare papillary histopathology, which appears to be characteristic for HLRCC. The derived linkage, loss of heterozygosity, and clinical data suggest that MCL and HLRCC are a single disease with a variable phenotype. The possibility that members of leiomyomatosis families are predisposed to renal cell cancer should be taken into account.

Entities:  

Mesh:

Year:  2001        PMID: 11549574      PMCID: PMC1850481          DOI: 10.1016/S0002-9440(10)61757-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

1.  Leiomyomatosis cutis et uteri.

Authors:  H Engelke; E Christophers
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1979

2.  Inherited susceptibility to uterine leiomyomas and renal cell cancer.

Authors:  V Launonen; O Vierimaa; M Kiuru; J Isola; S Roth; E Pukkala; P Sistonen; R Herva; L A Aaltonen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Allelotype of uterine leiomyomas.

Authors:  X Mao; R Barfoot; R A Hamoudi; D F Easton; A M Flanagan; M R Stratton
Journal:  Cancer Genet Cytogenet       Date:  1999-10-15

4.  [Multiple hereditary cutaneous leiomyoma. Study of a systemic case in a male subject related to a family with cutaneous leiomyomatosis and uterine fibromyomatosis].

Authors:  G Mezzadra
Journal:  Minerva Dermatol       Date:  1965-10

5.  Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43.

Authors:  N A Alam; S Bevan; M Churchman; E Barclay; K Barker; E E Jaeger; H M Nelson; E Healy; A C Pembroke; P S Friedmann; K Dalziel; E Calonje; J Anderson; P J August; M G Davies; R Felix; C S Munro; M Murdoch; J Rendall; S Kennedy; I M Leigh; D P Kelsell; I P Tomlinson; R S Houlston
Journal:  Am J Hum Genet       Date:  2001-03-14       Impact factor: 11.025

6.  9p Trisomy/18p distal monosomy and multiple cutaneous leiomyomata. Another specific chromosomal site (18pter) in dominantly inherited multiple tumors?

Authors:  J P Fryns; M Haspeslagh; A de Mûelenaere; H van Den Berghe
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

7.  Cutaneous leiomyomata with uterine leiomyomata.

Authors:  W B Reed; R Walker; R Horowitz
Journal:  Acta Derm Venereol       Date:  1973       Impact factor: 4.437

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Familial leiomyomatosis cutis et uteri (Reed's syndrome).

Authors:  M P García Muret; R M Pujol; A Alomar; J Calaf; J M de Moragas
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

10.  Familial cutaneous leiomyomatosis.

Authors:  H N Thyresson; W P Su
Journal:  J Am Acad Dermatol       Date:  1981-04       Impact factor: 11.527

View more
  43 in total

1.  Increased risk of cancer in patients with fumarate hydratase germline mutation.

Authors:  H J Lehtonen; M Kiuru; S K Ylisaukko-Oja; R Salovaara; R Herva; P A Koivisto; O Vierimaa; K Aittomäki; E Pukkala; V Launonen; L A Aaltonen
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

Review 2.  Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis.

Authors:  Markku Miettinen
Journal:  Mod Pathol       Date:  2014-01       Impact factor: 7.842

3.  Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report.

Authors:  Yasuhiro Iribe; Mitsuko Furuya; Yousuke Shibata; Masato Yasui; Makoto Funahashi; Junichi Ota; Hiromichi Iwashita; Yoji Nagashima; Hisashi Hasumi; Narihiko Hayashi; Kazuhide Makiyama; Keiichi Kondo; Reiko Tanaka; Masahiro Yao; Noboru Nakaigawa
Journal:  Fam Cancer       Date:  2020-07-15       Impact factor: 2.375

4.  Fumarase is involved in DNA double-strand break resection through a functional interaction with Sae2.

Authors:  Michael Leshets; Dharanidharan Ramamurthy; Michael Lisby; Norbert Lehming; Ophry Pines
Journal:  Curr Genet       Date:  2017-12-04       Impact factor: 3.886

Review 5.  Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC).

Authors:  Mei Hua Wong; Chuen Seng Tan; Soo Chin Lee; Yvonne Yong; Aik Seng Ooi; Joanne Ngeow; Min Han Tan
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

6.  UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.

Authors:  Youfeng Yang; Vladimir A Valera; Hesed M Padilla-Nash; Carole Sourbier; Cathy D Vocke; Manish A Vira; Mones S Abu-Asab; Gennady Bratslavsky; Maria Tsokos; Maria J Merino; Peter A Pinto; Ramaprasad Srinivasan; Thomas Ried; Len Neckers; W Marston Linehan
Journal:  Cancer Genet Cytogenet       Date:  2010-01-01

7.  LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer.

Authors:  Han Xie; Vladimir A Valera; Maria J Merino; Angela M Amato; Sabina Signoretti; William M Linehan; Vikas P Sukhatme; Pankaj Seth
Journal:  Mol Cancer Ther       Date:  2009-03-10       Impact factor: 6.261

Review 8.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

9.  Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.

Authors:  Jorge R Toro; Michael L Nickerson; Ming-Hui Wei; Michelle B Warren; Gladys M Glenn; Maria L Turner; Laveta Stewart; Paul Duray; Ousman Tourre; Nirmala Sharma; Peter Choyke; Pamela Stratton; Maria Merino; McClellan M Walther; W Marston Linehan; Laura S Schmidt; Berton Zbar
Journal:  Am J Hum Genet       Date:  2003-05-22       Impact factor: 11.025

10.  Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.

Authors:  Julian Sanz-Ortega; Cathy Vocke; Pamela Stratton; William Marston Linehan; Maria J Merino
Journal:  Am J Surg Pathol       Date:  2013-01       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.